QQ客服 官方微博 反馈留言

	MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation
	Wang, Yuan; Yan, Ping; Liu, Zhentao; Yang, Xiaodan; Wang, Yaping; Shen, Zhirong; Bai, Hua; Wang, Jie; Wang, Zhijie
	2016
卷号	7期号:3页码:279-287
关键词	Bevacizumab connexin MEK inhibitor non-small-cell lung cancer resistance
ISSN号	1759-7706
DOI	10.1111/1759-7714.12325
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6383100
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, Yuan,Yan, Ping,Liu, Zhentao,et al. MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation[J],2016,7(3):279-287.
APA	Wang, Yuan.,Yan, Ping.,Liu, Zhentao.,Yang, Xiaodan.,Wang, Yaping.,...&Wang, Zhijie.(2016).MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation.,7(3),279-287.
MLA	Wang, Yuan,et al."MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation".7.3(2016):279-287.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。